World's Largest Tocotrienol R&D Unit
DavosLife has established the world's leading tocotrienol R&D centers in Singapore and Malaysia to spearhead cutting-edge tocotrienol research into chronic diseases, dermatological applications, analytical chemistry and product innovations.
Our research has been published in leading journals such as the International Journal of Cancer, the British Journal of Cancer, Journal of Atherosclerosis and Thrombosis and the Pigment Cell & Melanoma Research. We are currently supporting 2 clinical trials in the USA and conducting 2 clinical trials in Malaysia using Naturale3.
For its commitment in advancing tocotrienol research, DavosLife is a distinguished recipient of the “2010 Asia Pacific Excellence Award in Vitamin E Research” from Frost and Sullivan.